Error: Could not add to watchlist. X

Keryx Biopharmaceuticals Inc

+ Watchlist
KERX:US
NASDAQ CM
6.18
USD
0.24
3.74%
As of 20:10:00 ET on 08/31/2015.
Open
6.35
Day Range
6.18 - 6.68
Volume
981,781
Previous Close
6.42
52Wk Range
5.25 - 18.42
1 Yr Return
-66.03%
Open
6.35
Day Range
6.18 - 6.68
Volume
981,781
Previous Close
6.42
52Wk Range
5.25 - 18.42
1 Yr Return
-66.03%
YTD Return
-56.33%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.36
Market Cap (m USD)
649.964
Shares Outstanding (m)
105.172
Price/Sales (TTM)
138.27
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Keryx Biopharmaceuticals, Inc. is focused on developing and commercializing pharmaceuticals for the treatment of renal disease. The Company's product candidate completed Phase 3 testing, pursuant to an SPA agreement with the FDA, for hyperphosphatemia in ESRD patients. The product candidate is also in Phase 2 for non-dialysis dependent CKD patients with iron-deficiency anemia.
ADDRESS
750 Lexington Avenue
New York, NY 10022
United States
PHONE
1-212-531-5965
  • Gregory P Madison "Greg"
    President/CEO
  • Scott A Holmes
    Chief Financial Officer
  • John F Neylan
    Chief Medical Officer
  • Brian R Adams
    VP/General Counsel
  • Lauren Fischer
    Director:Investor Relations
Show More